HMN 2025: What is the function of GLP-1 receptor agonists within the administration of weight problems

As Australia faces a turning mark in weight problems administration, researchers from Monash University have contributed new insights into the quickly evolving use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) similar to Ozempic within the Australian well being care system.

Originally developed for sort 2 diabetes, GLP-1 RAs have gained important traction globally for weight problems therapy. With 32% of Australians categorised as overweight in 2022 and the price of weight problems projected to succeed in $87.7 billion in Australia by 2032, a review for the Medical Journal of Australia highlights the important must fastidiously plan how these drugs are used.

Associate Professor Suong Le, a gastroenterologist at Monash University’s School of Clinical Sciences at Monash Health and CEO of Juno Healthcare, is a senior writer on the assessment.

“We’re at a watershed brief time period in weight problems administration. Because of how these new drugs work, they’re reworking the best way we view weight problems as a {condition},” Associate Professor Le stated. “It’s clear that weight problems isn’t just a life-style alternative, however ought to be considered a continual inflammatory illness with hyperlinks to cancer, mind perform and autoimmune situations.”

The assessment was led by Dr. Chris Kanellis—a graduate of drugs from Monash University and now a health care provider at Monash Health—and completely examines the Australian context, together with funding models, prescribing pathways, and equitable entry issues.

The researchers emphasize that many questions stay unanswered—particularly as demand for these medication grows quickly—together with tips for therapy length, prevention of rebound weight achieve after cessation, long-term funding models, and acceptable use in pediatric populations.

“The weight reduction scientific trials being performed within the US are huge when it comes to pattern dimension, partly as a result of GLP-1RAs are priced increased there than in Australia, and partly as a result of sheer dimension of the potential market,” Associate Professor Le defined.

“In Australia, we have to give attention to researching extra area of interest, particular use instances where these drugs could make a significant distinction in our scientific practice whereas additionally creating a better understanding on how precisely they result in improved cardiovascular well being, kidney perform and neuroprotection. This helps us develop a extra nuanced and scientifically complete understanding of weight problems as a {condition} and a danger issue for different ailments.

“We may not lead on massive RCTs, however we will completely lead in conducting focused scientific analysis in high-impact use instances.

“For instance, we have studied the usage of Mounjaro as a short-term, focused remedy to assist dialysis sufferers with weight problems lose sufficient to be safely waitlisted for kidney transplants.”

Associate Professor Le believes that researching short-term, targeted functions for the GLP-1RAs where there’s excessive financial affect is where Australia can have the best analysis contribution. Other promising scientific functions embody pre-surgery weight discount to attenuate surgical issues, and addressing weight problems sarcopenia, a {condition} involving low muscle mass in overweight sufferers that may impair immune perform.

Dr. Kanellis stated the publication additionally highlights the supportive analysis surroundings for college kids at Monash University.

“I’ve been very lucky to be surrounded by fantastic mentors and educators via my research and placements,” stated Dr. Kanellis. “I had a superb {experience} engaged on this venture and it has led to so many precious {learning} alternatives.”

Associate Professor Le stated, “This work is a good instance of the alternatives accessible to medical college students on the School of Clinical Sciences at Monash Health. We’ve created pathways for college kids to interact meaningfully in trade analysis positions.”

As Australia navigates these advanced well being care issues, this analysis from Associate Professor Le and Dr. Kanellis supplies vital steering on hanging a steadiness between addressing obesity-related well being considerations, whereas sustaining the monetary sustainability of our well being care system.